Sino Biopharmaceutical Limited

General ticker "SBMFF" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $14.6B (TTM average)

Sino Biopharmaceutical Limited does not follow the US Stock Market performance with the rate: -40.2%.

Estimated limits based on current volatility of 1.2%: low 0.69$, high 0.71$

Factors to consider:

  • Company pays dividends (semi-annually): last record date 2026-09-02, amount 0.01$ (Y2.86%)
  • Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.38$, 0.73$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.42$, 0.79$]

Similar symbols

Short-term SBMFF quotes

Long-term SBMFF plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue CNY28,866.16MM CNY31,012.97MM
Operating Expenses CNY22,730.60MM CNY24,375.37MM
Operating Income CNY6,135.56MM CNY6,637.61MM
Non-Operating Income CNY-858.09MM CNY126.61MM
Interest Expense CNY295.12MM CNY271.13MM
R&D Expense CNY5,234.90MM CNY5,714.86MM
Income(Loss) CNY5,277.47MM CNY6,764.22MM
Taxes CNY492.92MM CNY1,586.83MM
Net Income(Loss)* CNY3,499.83MM CNY2,282.88MM
Stockholders Equity CNY31,960.79MM CNY30,686.45MM
Inventory CNY2,373.14MM CNY2,257.80MM
Assets CNY65,408.07MM CNY76,048.21MM
Operating Cash Flow CNY6,615.12MM CNY9,291.82MM
Capital expenditure CNY960.10MM CNY1,702.93MM
Investing Cash Flow CNY-1,709.13MM CNY-12,413.76MM
Financing Cash Flow CNY-6,315.09MM CNY4,157.24MM
Earnings Per Share** CNY0.20 CNY0.13

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.